跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Metformin Hydrochloride/Sitagliptin Hydrochloride
首页
药物
Metformin Hydrochloride/Sitagliptin Hydrochloride
Metformin Hydrochloride/Sitagliptin Hydrochloride
未知生产厂商
订阅
生成 AI 研报
Share to Twitter
Share to Facebook
Share to LinkedIn
Share to Reddit
摘要
临床试验
审批记录
专利
每项发明一条,涵盖美国、欧洲、PCT 与中国的同族专利。
A MULTILAYER TABLET COMPRISING METFORMIN AND SITAGLIPTIN
EP 4799686 A1
申请人: SANOVEL ILAC SANAYI VE TICARET ANONIM SIRKETI
优先权: 2025
EP
WO
2 件公开
Preparation method of sitagliptin metformin hydrochloride compound preparation
CN 103463090 A
申请人: SHENZHEN HYBIO PHARMACEUTICAL
优先权: 2013
CN
Fruit stem cell medicine and preparation method thereof
CN 107648596 A
申请人: YE NING
优先权: 2017
CN
Chewable dosage forms containing sitagliptin and metformin
US 11096890 B2
申请人: MERCK SHARP & DOHME
优先权: 2018
US
Anti-diabetic pharmaceutical composition and preparation method thereof
CN 114929210 A
申请人: SALUS MEDICAL TECH LIMITED
优先权: 2020
CN
Sitagliptin metformin tablet preparation and preparation method thereof
CN 114306267 A
申请人: SHENZHEN JOHU PHARMACEUTICAL CO LTD
优先权: 2020
CN
Pharmaceutical composition containing sitagliptin and metformin, and preparation method thereof
CN 114042051 A
申请人: PINGGUANG PHARMACEUTICAL CO LTD
优先权: 2021
CN
Pharmaceutical composition containing sitagliptin phosphate and metformin hydrochloride and preparation method thereof
CN 116327769 A
申请人: CHONGQING SHENGHUAXI PHARMACEUTICAL CO LTD
优先权: 2021
CN
Method for preparing gastric retention type sitagliptin and metformin compound sustained-release tablet
CN 115708811 A
申请人: UNIV HEBEI MEDICAL
优先权: 2022
CN
FIXED-DOSE COMBINATION FORMULATIONS WITH LOW LEVEL OF IMPURITY PROFILE
WO 2025122076 A1
申请人: SANTA FARMA ILAC SANAYII A S
优先权: 2023
WO
第 1 / 2 页
上一页
下一页
药物
反馈